ixX pharma SA
26.3 FTEixX pharma reported revenue of €11.6m for the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026), with 26.3 full-time equivalents.
The score of ixX pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +20 % Equity +43 % Total assets +52 % Headcount (avg FTE) +38 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ixX pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €11.6m | ||||
| Net result | €1.69m | ||||
| Equity | €6.93m | ||||
| Cash | €1.35m | ||||
| EBITDA | €2.28m | ||||
| Total assets | €11.3m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
ixX pharma's financial analysis
- Solvency61.4%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ixX pharma
ixX pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0873.490.740
- VAT number
- BE0873490740
- Peppol
- Registered · 0208:0873490740 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 26 Apr 2005
- Registered office
- 2600 Antwerp
- Size
- Small · 26.3 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
ixX pharma (SA) has been based in Antwerp since 2005, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €11.6m, a net profit of €1.69m and equity of €6.93m. With 26.3 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 61.4%, above the median of its sector (46.0%).
Companies similar to ixX pharma
Companies in the same business, of comparable size and area, outside its group.
- DE Ceunynck Medical Wholesale of pharmaceutical and medical goods Aartselaar · balance sheet €16.9m
- Valerco Wholesale of pharmaceutical and medical goods Kontich · balance sheet €12.9m
- SPGL Ltd Wholesale of pharmaceutical and medical goods · balance sheet €1.01m
- Elekta Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €13.1m
- Romed Wholesale of pharmaceutical and medical goods Hoogstraten · balance sheet €9.52m
- Infinity Pharma Wholesale of pharmaceutical and medical goods Nazareth-De Pinte · balance sheet €18.8m
- Almirall Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €7.75m
- Recordati Wholesale of pharmaceutical and medical goods Jette · balance sheet €20.8m
Frequently asked questions about ixX pharma
What is the revenue of ixX pharma?
According to the 2025 annual accounts filed with the NBB, the revenue of ixX pharma amounts to 11,631,876 €.
What is the VAT number of ixX pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0873490740 for ixX pharma, if the company is VAT-registered. Its company number (CBE) is 0873.490.740.
Where is the registered office of ixX pharma?
According to the CBE register, the registered office of ixX pharma is in 2600 Antwerp.
What is the equity of ixX pharma?
At the close of the 2025 financial year, the equity of ixX pharma amounts to 6,926,124 €, a solvency of 61.4% of total assets.
How many people work at ixX pharma?
26.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages ixX pharma?
The register lists 6 active mandates at ixX pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ixX pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →